To ensure that a patient’s test is billed to their 2024 health benefits, testing must be started before the end of the year. For exome, genome, or Xpanded testing, if you do not expect parental samples to be received before the end of the year, please contact us at support@genedx.com to determine how to proceed.
Exome and genome results that deliver
With advanced genomic technologies, our rich internal database, and extensive clinical expertise, GeneDx’s industry-leading tests deliver clinically actionable results, faster.
Our comprehensive tests and advanced interpretation platform identify difficult-to-detect genetic variations and assess their contributions to disease. The result? Clear, actionable results and fewer variants of uncertain significance.
GeneDx has identified more than 400 new disease-gene relationships and developed novel tools for genomic data analysis—meaning more answers for more patients. See our recent publications.
At GeneDx, our goal is to provide clear, accurate, and meaningful answers so that healthcare providers, patients, families, and partners can take action. Join us: it all starts with a single test.
